CH624375A5 - - Google Patents
Download PDFInfo
- Publication number
- CH624375A5 CH624375A5 CH1355276A CH1355276A CH624375A5 CH 624375 A5 CH624375 A5 CH 624375A5 CH 1355276 A CH1355276 A CH 1355276A CH 1355276 A CH1355276 A CH 1355276A CH 624375 A5 CH624375 A5 CH 624375A5
- Authority
- CH
- Switzerland
- Prior art keywords
- compounds
- formula
- phenyl
- mixture
- acid
- Prior art date
Links
- -1 4-hydroxybenzoyl Chemical group 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 11
- ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 description 43
- 239000000203 mixture Substances 0.000 description 27
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000002253 acid Substances 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- 125000003545 alkoxy group Chemical group 0.000 description 7
- 239000000155 melt Substances 0.000 description 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 230000003509 anti-fertility effect Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000035558 fertility Effects 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 241000282421 Canidae Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 125000001999 4-Methoxybenzoyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C(*)=O 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 241000271566 Aves Species 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- CVFWKMJYJPBDPV-UHFFFAOYSA-N (4-methoxyphenyl)-(6-methoxy-3-phenyl-1h-inden-2-yl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=C(C=2C=CC=CC=2)C2=CC=C(OC)C=C2C1 CVFWKMJYJPBDPV-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000003433 contraceptive agent Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- BNZYBNYNPXKWCM-UHFFFAOYSA-N phenyl 4-methoxybenzoate Chemical compound C1=CC(OC)=CC=C1C(=O)OC1=CC=CC=C1 BNZYBNYNPXKWCM-UHFFFAOYSA-N 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- QJDUDPQVDAASMV-UHFFFAOYSA-M sodium;ethanethiolate Chemical compound [Na+].CC[S-] QJDUDPQVDAASMV-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- FHYTXIMJVHAGEX-UHFFFAOYSA-N (2-methoxyphenyl)-(3-phenyl-1h-inden-2-yl)methanone Chemical compound COC1=CC=CC=C1C(=O)C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C1 FHYTXIMJVHAGEX-UHFFFAOYSA-N 0.000 description 1
- YBTWSFJLDVXDJH-UHFFFAOYSA-N (3-ethoxyphenyl)-(3-phenyl-1h-inden-2-yl)methanone Chemical compound CCOC1=CC=CC(C(=O)C=2CC3=CC=CC=C3C=2C=2C=CC=CC=2)=C1 YBTWSFJLDVXDJH-UHFFFAOYSA-N 0.000 description 1
- AHKIAFDCGVTACB-UHFFFAOYSA-N (3-hydroxyphenyl)-(3-phenyl-1h-inden-2-yl)methanone Chemical compound OC1=CC=CC(C(=O)C=2CC3=CC=CC=C3C=2C=2C=CC=CC=2)=C1 AHKIAFDCGVTACB-UHFFFAOYSA-N 0.000 description 1
- RJQTVZQAFBFYGW-UHFFFAOYSA-N (4-hydroxyphenyl)-(6-hydroxy-3-phenyl-1h-inden-2-yl)methanone Chemical compound C1=CC(O)=CC=C1C(=O)C1=C(C=2C=CC=CC=2)C2=CC=C(O)C=C2C1 RJQTVZQAFBFYGW-UHFFFAOYSA-N 0.000 description 1
- VFBVZFWBELVADP-UHFFFAOYSA-N (4-methoxyphenyl)-(3-phenyl-1h-inden-2-yl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C1 VFBVZFWBELVADP-UHFFFAOYSA-N 0.000 description 1
- JFPAZHMKWHOGKS-UHFFFAOYSA-N (4-methoxyphenyl)-(6-methoxy-1-phenyl-3,4-dihydronaphthalen-2-yl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C(CCC1=CC(OC)=CC=C11)=C1C1=CC=CC=C1 JFPAZHMKWHOGKS-UHFFFAOYSA-N 0.000 description 1
- PMLGJZYJWQYIMX-UHFFFAOYSA-N (4-pentoxyphenyl)-(3-phenyl-1h-inden-2-yl)methanone Chemical compound C1=CC(OCCCCC)=CC=C1C(=O)C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C1 PMLGJZYJWQYIMX-UHFFFAOYSA-N 0.000 description 1
- CCHGMNUKXBEJRL-UHFFFAOYSA-N (6-hydroxy-3-phenyl-1h-inden-2-yl)-phenylmethanone Chemical compound C1C2=CC(O)=CC=C2C(C=2C=CC=CC=2)=C1C(=O)C1=CC=CC=C1 CCHGMNUKXBEJRL-UHFFFAOYSA-N 0.000 description 1
- KCYISNRBBKQKTG-UHFFFAOYSA-N (6-pentoxy-3-phenyl-1h-inden-2-yl)-phenylmethanone Chemical compound C1C2=CC(OCCCCC)=CC=C2C(C=2C=CC=CC=2)=C1C(=O)C1=CC=CC=C1 KCYISNRBBKQKTG-UHFFFAOYSA-N 0.000 description 1
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical class C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 1
- XHLHPRDBBAGVEG-UHFFFAOYSA-N 1-tetralone Chemical compound C1=CC=C2C(=O)CCCC2=C1 XHLHPRDBBAGVEG-UHFFFAOYSA-N 0.000 description 1
- PANZFQYXPMCHFD-UHFFFAOYSA-N 2,3-diphenyl-1h-indene Chemical compound C12=CC=CC=C2CC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 PANZFQYXPMCHFD-UHFFFAOYSA-N 0.000 description 1
- FRIGLBWVTJAEHM-UHFFFAOYSA-N 3,4-diphenyl-1,2-dihydronaphthalene Chemical class C1CC2=CC=CC=C2C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 FRIGLBWVTJAEHM-UHFFFAOYSA-N 0.000 description 1
- BJJQJLOZWBZEGA-UHFFFAOYSA-N 3-Methoxybenzenepropanoic acid Chemical compound COC1=CC=CC(CCC(O)=O)=C1 BJJQJLOZWBZEGA-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- MNALUTYMBUBKNX-UHFFFAOYSA-N 6-methoxy-3,4-dihydro-2h-naphthalen-1-one Chemical compound O=C1CCCC2=CC(OC)=CC=C21 MNALUTYMBUBKNX-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000272161 Charadriiformes Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000287182 Sturnidae Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- KMYRQKRMYZWBSA-UHFFFAOYSA-N [3-[(2-methylpropan-2-yl)oxy]phenyl]-(3-phenyl-1h-inden-2-yl)methanone Chemical compound CC(C)(C)OC1=CC=CC(C(=O)C=2CC3=CC=CC=C3C=2C=2C=CC=CC=2)=C1 KMYRQKRMYZWBSA-UHFFFAOYSA-N 0.000 description 1
- OHOPXAUVAFAKGY-UHFFFAOYSA-N [3-[(2-methylpropan-2-yl)oxy]phenyl]-(3-phenyl-6-propoxy-1h-inden-2-yl)methanone Chemical compound C1C2=CC(OCCC)=CC=C2C(C=2C=CC=CC=2)=C1C(=O)C1=CC=CC(OC(C)(C)C)=C1 OHOPXAUVAFAKGY-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002469 indenes Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- GWWKBLFPPUSKRQ-UHFFFAOYSA-N phenyl-(3-phenyl-6-propan-2-yloxy-1h-inden-2-yl)methanone Chemical compound C1C2=CC(OC(C)C)=CC=C2C(C=2C=CC=CC=2)=C1C(=O)C1=CC=CC=C1 GWWKBLFPPUSKRQ-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/625,992 US4017546A (en) | 1975-10-28 | 1975-10-28 | Novel antifertility agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH624375A5 true CH624375A5 (sv) | 1981-07-31 |
Family
ID=24508497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1355276A CH624375A5 (sv) | 1975-10-28 | 1976-10-27 |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US4017546A (sv) |
| JP (1) | JPS5253844A (sv) |
| AR (1) | AR221031A1 (sv) |
| AT (1) | AT347443B (sv) |
| AU (1) | AU503883B2 (sv) |
| BE (1) | BE847717A (sv) |
| BG (1) | BG27556A3 (sv) |
| CA (1) | CA1064926A (sv) |
| CH (1) | CH624375A5 (sv) |
| CS (1) | CS234003B2 (sv) |
| DD (1) | DD127462A5 (sv) |
| DE (1) | DE2647906C2 (sv) |
| DK (1) | DK484676A (sv) |
| ES (1) | ES452736A1 (sv) |
| FR (1) | FR2329265A1 (sv) |
| GB (1) | GB1562806A (sv) |
| GR (1) | GR61239B (sv) |
| HU (1) | HU176092B (sv) |
| IE (1) | IE43642B1 (sv) |
| IL (1) | IL50414A (sv) |
| MX (1) | MX4320E (sv) |
| NL (1) | NL7611973A (sv) |
| NZ (1) | NZ182426A (sv) |
| PH (2) | PH13486A (sv) |
| PL (1) | PL106987B1 (sv) |
| PT (1) | PT65754B (sv) |
| RO (1) | RO70754A (sv) |
| SE (1) | SE431086B (sv) |
| SU (1) | SU654164A3 (sv) |
| YU (1) | YU262176A (sv) |
| ZA (1) | ZA766441B (sv) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4323707A (en) * | 1975-10-28 | 1982-04-06 | Eli Lilly And Company | Antifertility compounds |
| US4230862A (en) * | 1975-10-28 | 1980-10-28 | Eli Lilly And Company | Antifertility compounds |
| US4400543A (en) * | 1975-10-28 | 1983-08-23 | Eli Lilly And Company | 3-Phenyl-4-benzoyl-1,2-dihydronaphthalenes |
| US4017546A (en) * | 1975-10-28 | 1977-04-12 | Eli Lilly And Company | Novel antifertility agents |
| US5552401A (en) * | 1995-02-28 | 1996-09-03 | Eli Lilly And Company | 2-benzyl-3-arylbenzothiophenes |
| US6107346A (en) * | 1997-08-11 | 2000-08-22 | Eli Lilly And Company | Methods for treating hyperlipidemia |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2551316A (en) * | 1948-02-20 | 1951-05-01 | Searle & Co | 9-aminoalkyl 9-alkanoyl 9, 10 dihydroanthracenes |
| US3396169A (en) * | 1966-10-26 | 1968-08-06 | Upjohn Co | Substituted 2-phenyl-1-(tertiary-aminoalkoxy) phenyl-3, 4-dihydronaphthalenes |
| US3274213A (en) * | 1961-09-05 | 1966-09-20 | Upjohn Co | Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes |
| US3862232A (en) * | 1963-07-03 | 1975-01-21 | Upjohn Co | 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof |
| US3293263A (en) * | 1963-12-09 | 1966-12-20 | Upjohn Co | Diphenylbenzocycloalkenes |
| US3519675A (en) * | 1964-06-01 | 1970-07-07 | Upjohn Co | 1,2-diphenyl-3,4-dihydronaphthalenes and 2,3-diphenylindenes |
| US3320271A (en) * | 1964-06-01 | 1967-05-16 | Upjohn Co | 1, 2-diphenyl-3, 4-dihydronaphthalenes and 2, 3-diphenylindenes |
| US3483293A (en) * | 1967-12-15 | 1969-12-09 | Upjohn Co | Method for controlling birds and rodents |
| US4017546A (en) * | 1975-10-28 | 1977-04-12 | Eli Lilly And Company | Novel antifertility agents |
-
1975
- 1975-10-28 US US05/625,992 patent/US4017546A/en not_active Expired - Lifetime
-
1976
- 1976-09-02 AU AU17407/76A patent/AU503883B2/en not_active Expired
- 1976-09-05 IL IL50414A patent/IL50414A/xx unknown
- 1976-10-20 MX MX764987U patent/MX4320E/es unknown
- 1976-10-20 JP JP51126786A patent/JPS5253844A/ja active Granted
- 1976-10-21 NZ NZ182426A patent/NZ182426A/xx unknown
- 1976-10-21 CA CA263,843A patent/CA1064926A/en not_active Expired
- 1976-10-22 DE DE2647906A patent/DE2647906C2/de not_active Expired
- 1976-10-22 HU HU76EI712A patent/HU176092B/hu unknown
- 1976-10-22 PH PH19041A patent/PH13486A/en unknown
- 1976-10-25 GR GR52002A patent/GR61239B/el unknown
- 1976-10-25 PT PT65754A patent/PT65754B/pt unknown
- 1976-10-25 GB GB44176/76A patent/GB1562806A/en not_active Expired
- 1976-10-26 RO RO7688225A patent/RO70754A/ro unknown
- 1976-10-26 SU SU762414100A patent/SU654164A3/ru active
- 1976-10-26 ES ES452736A patent/ES452736A1/es not_active Expired
- 1976-10-27 YU YU02621/76A patent/YU262176A/xx unknown
- 1976-10-27 ZA ZA00766441A patent/ZA766441B/xx unknown
- 1976-10-27 DK DK484676A patent/DK484676A/da not_active Application Discontinuation
- 1976-10-27 IE IE2373/76A patent/IE43642B1/en unknown
- 1976-10-27 SE SE7611952A patent/SE431086B/sv not_active IP Right Cessation
- 1976-10-27 CH CH1355276A patent/CH624375A5/de not_active IP Right Cessation
- 1976-10-28 BE BE1007723A patent/BE847717A/xx not_active IP Right Cessation
- 1976-10-28 PL PL1976193327A patent/PL106987B1/pl unknown
- 1976-10-28 AR AR265275A patent/AR221031A1/es active
- 1976-10-28 AT AT800676A patent/AT347443B/de not_active IP Right Cessation
- 1976-10-28 FR FR7632512A patent/FR2329265A1/fr active Granted
- 1976-10-28 NL NL7611973A patent/NL7611973A/xx not_active Application Discontinuation
- 1976-10-28 DD DD195509A patent/DD127462A5/xx unknown
- 1976-10-28 BG BG034553A patent/BG27556A3/xx unknown
- 1976-10-28 CS CS766972A patent/CS234003B2/cs unknown
- 1976-11-24 US US05/744,488 patent/US4075223A/en not_active Expired - Lifetime
-
1979
- 1979-09-17 PH PH23040A patent/PH14545A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2647907C2 (de) | 2-Phenyl-3-aroylbenzothiophene und Verfahren zu ihrer Herstellung | |
| DE2647864C2 (de) | 2-Aroyl-3-phenylbenzothiophenverbindungen und Verfahren zu ihrer Herstellung | |
| EP0013376B1 (de) | Ein Isoxazolderivat, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Mittel | |
| EP0004279B1 (de) | Verfahren zur Herstellung von 4-Pyridon-3-carbonsäuren, 1-Cyclopropyl-4-Pyridon-3-Carbonsäurederivate und diese enthaltende Arzneimittel | |
| DE3033157A1 (de) | 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel | |
| CH636839A5 (de) | 4-(2-oxo-1-cycloalkylidenmethyl)-phenylessigsaeurederivate, sowie verfahren zu deren herstellung und pharmazeutisch zulaessige salze solcher verbindungen. | |
| EP0023594A1 (de) | Trans-Chinazolinderivate, Verfahren zu ihrer Herstellung, Zwischenprodukte und Arzneimittel enthaltend solche Chinazolinderivate | |
| DE2941869C2 (sv) | ||
| EP0064027B1 (de) | Neue Benzodioxolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| CH624375A5 (sv) | ||
| CH642077A5 (de) | 3-fluor-10-piperazino-8-substituierte 10,11-dihydrodibenzo-(b,f)-thiepine, deren saeureadditionssalze, verfahren zur herstellung derselben und diese enthaltende zubereitungen. | |
| DE2931418A1 (de) | Neue imidazochinoxaline und deren salze, verfahren zu deren herstellung, deren verwendung als arzneimittel und die sie enthaltenden pharmazeutischen zusammensetzungen | |
| DE2546738A1 (de) | Benzophenonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel | |
| DE2448438A1 (de) | 2-substituierte und 2,2-disubstituierte eckige klammer auf 1,3-dioxoindanyloxy(oder -thio) eckige klammer zu -alkancarbonsaeuren und verfahren zur herstellung derselben | |
| DE2645865C2 (sv) | ||
| DE3111155A1 (de) | 5,6-dimethyl-pyrrolo (2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE2646213A1 (de) | Aroylphenylnaphthaline und verfahren zu ihrer herstellung | |
| DE2610501A1 (de) | 1,4-disubstituierte piperazinverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE1921049A1 (de) | Neue organische Verbindungen und Verfahren zu ihrer Herstellung | |
| DE1695963A1 (de) | Cycloalkenamin-p-benzochinonaddukte und Verfahren zu ihrer Herstellung | |
| DE1568848C3 (de) | Trans-Isomere von Alkenderivaten und Verfahren zu Ihrer Herstellung | |
| DE2600182A1 (de) | Psychotrop und antimikrobiell wirksame polysubstituierte 10-piperazinodibenzo (b,f) thiepinderivate | |
| DE1927452B2 (de) | 2,3-dihydrobenzofuran-2-carbonsaeuren und deren salze mit pharmakologisch vertraeglichen anorganischen oder organischen basen und verfahren zur deren herstellung sowie arzneimittel mit einem gehalt an diesen verbindungen | |
| DE3016616C2 (de) | 2-(6-Methoxy-2-naphthyl)-propylönanthat, Verfahren zu seiner Herstellung und diese enthaltende Arzneimittel | |
| EP0107623A1 (de) | Neue Benzodioxolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |